Technical Analysis for STIM - Neuronetics, Inc.

Grade Last Price % Change Price Change
grade F 9.9 -1.98% -0.20
STIM closed down 1.98 percent on Tuesday, August 20, 2019, on 43 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical STIM trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Multiple of Ten Bearish Other 0.00%
Oversold Stochastic Weakness 0.00%
Oversold Stochastic Weakness -1.98%
Narrow Range Bar Range Contraction -1.00%
NR7 Range Contraction -1.00%
Oversold Stochastic Weakness -1.00%
Wide Bands Range Expansion 2.59%
Oversold Stochastic Weakness 2.59%
Stochastic Buy Signal Bullish 2.17%

Older signals for STIM ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:
Profile
Neuronetics Inc is a commercial stage medical technology company. It is focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.
Health Psychiatry Neurotechnology Corcept Therapeutics Treatment Of Depression
Is STIM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Aug 9 Neuronetics, Inc.'s (STIM) CEO Chris Thatcher on Q2 2019 Results - Earnings Call Transcript
Aug 8 Neuronetics, Inc. (STIM) Q2 2019 Earnings Call Transcript
Aug 7 Mixed shelf filing roundup
Aug 6 Neuronetics (STIM) Reports Q2 Loss, Tops Revenue Estimates
Aug 6 Neuronetics EPS beats by $0.01, beats on revenue
Aug 6 Neuronetics Reports Second Quarter 2019 Financial and Operating Results
Aug 6 The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering
Aug 3 Stocks To Watch: Trading Tariff Turbulence
Aug 1 Neuronetics® Announces First TMS Patient Treated Under New Japan Reimbursement Policy
Jul 29 Neuronetics® Launches TrakStar® Plus Patient Data Management System to Maximize Physician Time with Patients
See more STIM news...
Indicators
Indicator Value
52 Week High 39.39
52 Week Low 8.9
Average Volume 85,895
200-Day Moving Average 15.553
50-Day Moving Average 11.533
20-Day Moving Average 10.6265
10-Day Moving Average 9.972
Average True Range 0.6444
ADX 16.42
+DI 15.3531
-DI 18.5648
Chandelier Exit (Long, 3 ATRs ) 10.6368
Chandelier Exit (Short, 3 ATRs ) 11.473199999999999
Upper Bollinger Band 12.1555
Lower Bollinger Band 9.0975
Percent B (%b) 0.26
BandWidth 28.777114
MACD Line -0.575
MACD Signal Line -0.5532
MACD Histogram -0.0217
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.37
Resistance 3 (R3) 10.42 10.31 10.29
Resistance 2 (R2) 10.31 10.19 10.29 10.26
Resistance 1 (R1) 10.11 10.12 10.06 10.06 10.24
Pivot Point 10.00 10.00 9.98 9.98 10.00
Support 1 (S1) 9.80 9.88 9.75 9.75 9.56
Support 2 (S2) 9.69 9.81 9.67 9.54
Support 3 (S3) 9.49 9.69 9.51
Support 4 (S4) 9.44